Business | |||||||
NEWS | |||||||
From Twitter chaos to TikTok bans to the metaverse, social media had a rocky 2022 Facebook burned through billions of dollars trying to make the metaverse happen. Elon Musk bought Twitter for $44 billion and plunged the company into chaos, sending advertisers and some power users fleeing. Across Silicon Valley, tens ...
| |||||||
HPE Says 'There Are No Discussions With Nutanix' The HPE statement comes after Dealreporter reported that HPE is no longer in talks to buy Nutanix, sending Nutanix shares down seven percent in early afternoon trading on Friday. ARTICLE TITLE HERE ...
| |||||||
Target recalls Pillowfort weighted blankets for kids after two deaths Target stores are recalling more than 200,000 weighted blankets for children that have been sold by the retailer from December 2018 through September 2022. The Pillowfort brand blankets can trap children inside if they unzip them and enter the blanket, ...
| |||||||
Bitcoin miner Core Scientific approved for $37.5 mln bankruptcy loan Austin, Texas-based Core Scientific filed for bankruptcy on Wednesday, blaming the sharp decline in bitcoin prices, rising energy costs for bitcoin mining and a $7 million unpaid debt from U.S. crypto lender Celsius Network, one of its biggest customers.
| |||||||
FTC Requests Comment on Potential Revisions to Green Guides The Request seeks information on a wide range of environmental marketing claims both currently and potentially covered by the Green Guides – including claims related to recycling, climate change, energy use and efficiency, and sustainability. The ...
| |||||||
FDA Approves Bispecific Antibody Mosunetuzumab for R/R Follicular Lymphoma The FDA has approved mosunetuzumab-axgb (Lunsumio; Genentech), a bispecific antibody for the treatment of adults with relapsed or refractory follicular lymphoma (R/R FL) after 2 or more prior lines of systemic therapy. In July 2022, FDA had granted ...
| |||||||
Blood Pressure Medication Recalled for Cancer Risk Lupin Pharmaceuticals has recalled four lots of the blood pressure medication Quinapril after detection of the cancer-causing impurity nitrosamine above the acceptable daily intake level set by the Food and Drug Administration (FDA).
| |||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar